Skip to content

Effectiveness of Priovi, A Digital Self-help Tool, In Patients with Borderline Personality Disorder – a single-blinded Randomized Controlled Trial (EPADIP- BPD)

Effectiveness of Priovi, A Digital Self-help Tool, In Patients with Borderline Personality Disorder – a single-blinded Randomized Controlled Trial (EPADIP- BPD) - EPADIP-BPD

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028888
Enrollment
580
Registered
2022-04-27
Start date
2022-05-03
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F60.31: Emotionally unstable personality disorder: Borderline

Interventions

Group 1: Intervention group: access to the online program priovi for 360 days in addtion to care as usual Group 2: TAU-waitlist control group: care as usual, will be granted access to priovi after T2

Sponsors

GAIA AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: diagnosis of BPD (assessed via telephone interview via SCID-5-PD) borderline severity score (cut-off) of = 1.07 on the Borderline Symptoms List-23 (BSL-23) consent to emergency plan for suicidal crises consent to participation

Exclusion criteria

Exclusion criteria: Primary diagnosis of substance use disorder Primary Psychotic disorder (except transitory paranoid ideas that can be concomitant with BPS and in which the ability to test reality is mostly preserved)

Design outcomes

Primary

MeasureTime frame
Severity of Borderline Symptoms, assessed via the Borderline Symptom List – 23 (BSL-23) at T1 (3 months after baseline assessment)

Secondary

MeasureTime frame
Responder Analysis of severity of borderline symptoms Mental Health-related Quality of Life, assessed via the SF-12 (score of mental health domain) Depression, assessed via the Patient Health Questionnaire (PHQ-9) Anxiety, assessed via the Generalized Anxiety Disorder Assessment (GAD-7) Ability to Work, assessed via the Work and Social Assessment Scale (WSAS) Clinical Course, assessed via a semi-structured questionnaire at T1 (3 months after baseline assessment)

Countries

Germany

Contacts

Public ContactLinda Betz

GAIA AG

team@priovi-studie.de040349930495

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026